When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VTGN - VistaGen secures new Korean patent for PH10 in depression
VistaGen Therapeutics Inc.
VistaGen Therapeutics (VTGN) announces that the Korean Intellectual Property Office has issued a Decision to Grant Patent Application No. 10-2015-7020176 related to methods of treating depressive disorder with VistaGen's PH10.The patent is not set to expire earlier than 2034.PH10 is an investigational neuroactive nasal spray designed to have rapid-onset therapeutic potential in several neuropsychiatric indications involving major depressive disorder.Shares up 3% premarket.